Abstract
No AccessJournal of UrologyUrological Survey1 Nov 2020Re: Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia Tomas L. GrieblingMD, MPH Tomas L. GrieblingTomas L. Griebling More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001248.04AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Re: Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia." The Journal of Urology, 204(5), p. 1076 Suggested Reading : Cognitive impairment in men with prostate cancer treated with androgen deprivation therapy: a systematic review and meta-analysis. J Urol 2018; 199: 1417. Link, Google Scholar : Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol 2011; 185: 833. Link, Google Scholar © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 204Issue 5November 2020Page: 1076-1076 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Tomas L. Griebling More articles by this author Expand All Advertisement PDF DownloadLoading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
